Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06433557
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-05-23
Brief Title:
A Phase 2 Clinical Trial to Evaluate Efficacy Safety and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia
Sponsor:
Ascendis Pharma Growth Disorders AS
Organization:
Ascendis Pharma AS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-23
First Submit QC Date:
May 23 2024
Study First Post Date:
2024-05-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-06
Last Update Post Date:
2024-06-12
Last Update Post Date Type:
ACTUAL